Skip to main content
Erschienen in:

02.05.2023 | Original Article

A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time

verfasst von: Ryo Karita, Hidemi Suzuki, Yuki Onozato, Taisuke Kaiho, Terunaga Inage, Takamasa Ito, Kazuhisa Tanaka, Yuichi Sakairi, Ichiro Yoshino

Erschienen in: Surgery Today | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Latent lymph node metastasis is a clinical concern in the surgical treatment of non-small cell lung cancer (NSCLC). The present study identified a simple tool, including the volume-doubling time (VDT), for evaluating the risk of nodal metastasis.

Methods

We reviewed, retrospectively, 560 patients who underwent radical resection for cN0M0 NSCLC. The whole tumor VDT and solid component VDT (SVDT) for differentiating the histological type and adenocarcinoma subtype were analyzed and a nomogram was constructed using variables selected through a stepwise selection method. The model was assessed through a calibration curve and decision curve analysis (DCA).

Results

Lymph node metastases were detected in 89 patients (15.9%). The SVDT tended to be longer in patients with adenocarcinoma (294.5 days, p < 0.0001) than in those with other histological types of NSCLC, but was shorter when the solid/micropapillary component was predominant (127.0 days, p < 0.0001). The selected variables (tumor location, solid component diameter, consolidation tumor ratio, SVDT, and carcinoembryonic antigen) demonstrated significant differences and were used for the nomogram. The calibration curve indicated consistency, and the DCA showed validity across most threshold ranges from 0 to 68%.

Conclusions

The established nomogram is a useful tool for the preoperative prediction of lymph node metastasis, and the SVDT was the most influential factor in the nomogram.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Collaboration GB of DC, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017. Jama Oncol. 2019;5:1749–68. Collaboration GB of DC, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017. Jama Oncol. 2019;5:1749–68.
2.
Zurück zum Zitat Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) Edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRefPubMed Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) Edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRefPubMed
3.
Zurück zum Zitat National Comprehensive Cancer Network clinical practice guidelines in oncology non-small cell lung cancer. Version 3.2022. National Comprehensive Cancer Network clinical practice guidelines in oncology non-small cell lung cancer. Version 3.2022.
4.
Zurück zum Zitat Birim Ö, Kappetein AP, Stijnen T, Bogers AJJC. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg. 2005;79:375–82.CrossRefPubMed Birim Ö, Kappetein AP, Stijnen T, Bogers AJJC. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg. 2005;79:375–82.CrossRefPubMed
5.
Zurück zum Zitat Shen G, Lan Y, Zhang K, Ren P, Jia Z. Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. PLoS ONE. 2017;12: e0173104.CrossRefPubMedPubMedCentral Shen G, Lan Y, Zhang K, Ren P, Jia Z. Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis. PLoS ONE. 2017;12: e0173104.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Houdu B, Lasnon C, Licaj I, Thomas G, Do P, Guizard A-V, et al. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer. Eur J Nucl Med Mol. 2019;I(46):421–8.CrossRef Houdu B, Lasnon C, Licaj I, Thomas G, Do P, Guizard A-V, et al. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer. Eur J Nucl Med Mol. 2019;I(46):421–8.CrossRef
7.
Zurück zum Zitat Dhopeshwarkar MR, Roberts HC, Paul NS, Dong Z, Tsao M, Menezes RJ. Screen-detected Lung cancer a retrospective analysis of CT appearance. Acad Radiol. 2011;18:1270–6.CrossRefPubMed Dhopeshwarkar MR, Roberts HC, Paul NS, Dong Z, Tsao M, Menezes RJ. Screen-detected Lung cancer a retrospective analysis of CT appearance. Acad Radiol. 2011;18:1270–6.CrossRefPubMed
8.
Zurück zum Zitat Muraoka Y, Yoshida Y, Nakagawa K, Ito K, Watanabe H, Narita T, et al. Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection. J Thorac Cardiovasc Surg. 2022;163:1656-1665.e3.CrossRefPubMed Muraoka Y, Yoshida Y, Nakagawa K, Ito K, Watanabe H, Narita T, et al. Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection. J Thorac Cardiovasc Surg. 2022;163:1656-1665.e3.CrossRefPubMed
9.
Zurück zum Zitat Dong X, Qiu X, Liu Q, Jia J. Endobronchial ultrasound-guided transbronchial needle aspiration in the mediastinal staging of non-small cell lung cancer: a meta-analysis. Ann Thorac Surg. 2013;96:1502–7.CrossRefPubMed Dong X, Qiu X, Liu Q, Jia J. Endobronchial ultrasound-guided transbronchial needle aspiration in the mediastinal staging of non-small cell lung cancer: a meta-analysis. Ann Thorac Surg. 2013;96:1502–7.CrossRefPubMed
10.
Zurück zum Zitat Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomized lung cancer screening trial. Lung Cancer. 2006;54:177–84.CrossRefPubMed Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomized lung cancer screening trial. Lung Cancer. 2006;54:177–84.CrossRefPubMed
11.
Zurück zum Zitat Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON Study: cancer risk during 1 year of follow-up. Radiology. 2009;250:264–72.CrossRefPubMed Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON Study: cancer risk during 1 year of follow-up. Radiology. 2009;250:264–72.CrossRefPubMed
13.
Zurück zum Zitat Miura K, Hamanaka K, Koizumi T, Kawakami S, Kobayashi N, Ito K. Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients. J Cardiothorac Surg. 2019;14:57.CrossRefPubMedPubMedCentral Miura K, Hamanaka K, Koizumi T, Kawakami S, Kobayashi N, Ito K. Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients. J Cardiothorac Surg. 2019;14:57.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Park S, Lee SM, Kim S, Lee J-G, Choi S, Do K-H, et al. Volume doubling times of lung adenocarcinomas: correlation with predominant histologic subtypes and prognosis. Radiology. 2020;295: 191835.CrossRef Park S, Lee SM, Kim S, Lee J-G, Choi S, Do K-H, et al. Volume doubling times of lung adenocarcinomas: correlation with predominant histologic subtypes and prognosis. Radiology. 2020;295: 191835.CrossRef
15.
Zurück zum Zitat Nakahashi K, Shiono S, Nakatsuka M, Endo M. Prediction of lymph node metastasis of clinical stage IA non-small cell lung cancer based on the tumor volume doubling time. Surg Today. 2022;52:1063–71.CrossRefPubMed Nakahashi K, Shiono S, Nakatsuka M, Endo M. Prediction of lymph node metastasis of clinical stage IA non-small cell lung cancer based on the tumor volume doubling time. Surg Today. 2022;52:1063–71.CrossRefPubMed
16.
Zurück zum Zitat Usuda K, Saito Y, Sagawa M, Sato M, Kanma K, Takahashi S, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer. 1994;74:2239–44.CrossRefPubMed Usuda K, Saito Y, Sagawa M, Sato M, Kanma K, Takahashi S, et al. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer. 1994;74:2239–44.CrossRefPubMed
18.
Zurück zum Zitat Moreira AL, Ocampo PSS, Xia Y, Zhong H, Russell PA, Minami Y, et al. A grading system for invasive pulmonary adenocarcinoma: a proposal from the international association for the study of lung cancer pathology committee. J Thorac Oncol. 2020;15:1599–610.CrossRefPubMedPubMedCentral Moreira AL, Ocampo PSS, Xia Y, Zhong H, Russell PA, Minami Y, et al. A grading system for invasive pulmonary adenocarcinoma: a proposal from the international association for the study of lung cancer pathology committee. J Thorac Oncol. 2020;15:1599–610.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H. A prediction model for N2 disease in T1 non–small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144:1360–4.CrossRefPubMed Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H. A prediction model for N2 disease in T1 non–small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144:1360–4.CrossRefPubMed
20.
Zurück zum Zitat Wang Z, Wu Y, Wang L, Gong L, Han C, Liang N, et al. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm. Future Oncol. 2021;17:2005–13.CrossRefPubMed Wang Z, Wu Y, Wang L, Gong L, Han C, Liang N, et al. Predicting occult lymph node metastasis by nomogram in patients with lung adenocarcinoma ≤2 cm. Future Oncol. 2021;17:2005–13.CrossRefPubMed
21.
Zurück zum Zitat Kent M, Landreneau R, Mandrekar S, Hillman S, Nichols F, Jones D, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–55.CrossRefPubMed Kent M, Landreneau R, Mandrekar S, Hillman S, Nichols F, Jones D, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg. 2013;96:1747–55.CrossRefPubMed
22.
Zurück zum Zitat Mokhles S, Macbeth F, Treasure T, Younes RN, Rintoul RC, Fiorentino F, et al. Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small cell lung cancer: a systematic review of randomized trials and a meta-analysis. Eur J Cardio-thorac. 2017;51:1149–56.CrossRef Mokhles S, Macbeth F, Treasure T, Younes RN, Rintoul RC, Fiorentino F, et al. Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small cell lung cancer: a systematic review of randomized trials and a meta-analysis. Eur J Cardio-thorac. 2017;51:1149–56.CrossRef
23.
Zurück zum Zitat Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg. 2002;124:499–502.CrossRefPubMed Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg. 2002;124:499–502.CrossRefPubMed
Metadaten
Titel
A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time
verfasst von
Ryo Karita
Hidemi Suzuki
Yuki Onozato
Taisuke Kaiho
Terunaga Inage
Takamasa Ito
Kazuhisa Tanaka
Yuichi Sakairi
Ichiro Yoshino
Publikationsdatum
02.05.2023
Verlag
Springer Nature Singapore
Erschienen in
Surgery Today / Ausgabe 1/2024
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02695-9

Neu im Fachgebiet Chirurgie

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.